Search - tctmd.com

Displaying 421 - 440 of 442

Sort: Relevancy | Date

Presentation TVT 2012

MitraClip Results in Low- and High-Risk Degenerative MR: Emerging Data and Integrated Recommendations

Presenter: Ted Feldman

June 03, 2012

Presentation TVT 2012

Echocardiographic Primer: Assessments for "Classic" MitraClip Eligibility

Presenter: Samir Kapadia

June 03, 2012

Presentation TVT 2012

Critical Appraisal 2: MitraClip for Functional MR: Knowns, Unknowns, and Limitations

Presenter: Paul Grayburn

June 03, 2012

News Industry News

Abbott Reinforces Global Vascular Leadership with New Data on Innovative Technologies at ACC 2012

March 20, 2012

News Daily News

Experts Give Their Picks for Most Important Developments of 2011

Jason Kahn

March 08, 2012

News Daily News

Mitral Repair Can Augment Heart Function in CABG Patients

Caitlin E. Cox

March 04, 2012

News Daily News

La Reparación Mitral Puede Aumentar la Función Cardíaca en Pacientes sometidos a CABG

Caitlin E. Cox

March 04, 2012

News Daily News

Early Percutaneous Intervention May Help Asymptomatic Mitral Stenosis

Caitlin E. Cox

January 17, 2012

News Daily News

EVEREST II Registry Looks at MitraClip in High-Risk Patients

Jason Kahn

January 04, 2012

Presentation TCT 2012

Quality Of Life Changes In High Risk Patients after Percutaneous Mitral Valve Repair with Mitraclip

Presenter: Maurizio Taramasso, Paolo Denti, Micaela Cioni, Nicola Buzzatti, Antonio Colombo, Ottavio Alfieri, Francesco Maisano

January 03, 2012

Presentation TCT 2012

MitraClip Treatment of Functional Mitral Regurgitation in Patients not Amenable to Surgery

Presenter: Volker Rudolph, Michael Schlueter, Olaf Franzen, Malgorzata Knap, Hendrik Treede, Hermann Reichenspurner, Stefan Blankenberg, Stephan Baldus

January 03, 2012

Presentation TCT 2012

MitraClip for Patients With Mitral Regurgitation Who are Ineligible for Surgical Repair or Replacement: A UK Based Cost-Utility Analysis

Presenter: Stuart Mealing

January 03, 2012

Presentation TCT 2012

Functional vs. Degenerative Mitral Regurgitation in Patients not Amenable to Surgery Undergoing MitraClip Treatment.

Presenter: Stephan Baldus, Volker Rudolph, Michael Schlueter, Olaf Franzen, Malgorzata Knap, Hendrik Treede, Hermann Reichenspurner, Stefan Blankenberg

January 03, 2012

Presentation TCT 2012

EVEREST II High Surgical Risk Cohort: Clinical Benefit by MR Grade in High Surgical Risk Patients One Year Following MitraClip Therapy.

Presenter: Paul Grayburn, Saibal Kar, Ted Feldman, Donald Glower, Elyse Foster, Laura Mauri

January 03, 2012

News Conference News

Mitral Regurgitation Surgical Repair Rates, Durability Continue to Improve

November 07, 2011

News Industry News

Abbott to Present New Data for Key Vascular Products at TCT 2011

November 03, 2011

News Daily News

TAVR Travelers: Medical Tourism Gaining Ground

L.A. McKeown

September 26, 2011

News Conference News

ACC Scientific Session-i2 Summit 2011: The Devil Is in the Details

Caitlin E. Cox

April 08, 2011

News Conference News

EVEREST II: Two-Year Outcomes Show Positive, Negative Aspects of MitraClip

April 04, 2011

News Industry News

Data from Landmark Clinical Trial of Abbott's MitraClip® System Demonstrate Durable Clinical Benefits for Patients with Mitral Regurgitation Two Years After Treatment

April 04, 2011

Advertisement

MitraClip Results in Low- and High-Risk Degenerative MR: Emerging Data and Integrated Recommendations

Echocardiographic Primer: Assessments for "Classic" MitraClip Eligibility

Critical Appraisal 2: MitraClip for Functional MR: Knowns, Unknowns, and Limitations

Abbott Reinforces Global Vascular Leadership with New Data on Innovative Technologies at ACC 2012

Experts Give Their Picks for Most Important Developments of 2011

Mitral Repair Can Augment Heart Function in CABG Patients

La Reparación Mitral Puede Aumentar la Función Cardíaca en Pacientes sometidos a CABG

Early Percutaneous Intervention May Help Asymptomatic Mitral Stenosis

EVEREST II Registry Looks at MitraClip in High-Risk Patients

Quality Of Life Changes In High Risk Patients after Percutaneous Mitral Valve Repair with Mitraclip

MitraClip Treatment of Functional Mitral Regurgitation in Patients not Amenable to Surgery

MitraClip for Patients With Mitral Regurgitation Who are Ineligible for Surgical Repair or Replacement: A UK Based Cost-Utility Analysis

Functional vs. Degenerative Mitral Regurgitation in Patients not Amenable to Surgery Undergoing MitraClip Treatment.

EVEREST II High Surgical Risk Cohort: Clinical Benefit by MR Grade in High Surgical Risk Patients One Year Following MitraClip Therapy.

Mitral Regurgitation Surgical Repair Rates, Durability Continue to Improve

Abbott to Present New Data for Key Vascular Products at TCT 2011

TAVR Travelers: Medical Tourism Gaining Ground

ACC Scientific Session-i2 Summit 2011: The Devil Is in the Details

EVEREST II: Two-Year Outcomes Show Positive, Negative Aspects of MitraClip

Data from Landmark Clinical Trial of Abbott's MitraClip® System Demonstrate Durable Clinical Benefits for Patients with Mitral Regurgitation Two Years After Treatment

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content